EquityFlowCompanies › Medmain

Medmain

Healthtech · Fukuoka, JP

Develops PidPort, an AI digital-pathology diagnosis solution.

Funding history

DateRoundAmount
Jul 2022Funding round
Medmain, maker of AI pathology tool PidPort, raised 300M JPY from PSP alongside a business alliance.
$2.2M

Investors

PSP

Similar companies in Healthtech

Explore funding flow on EquityFlow →